)
Visual24 Oct 2025
The rise of Alphabet
ImmunoPrecise Antibodies (IPA) investor relations material
ImmunoPrecise Antibodies Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary15 Sep, 2025
Executive summary
Achieved record Q1 revenue of $7.6 million, up 45% year over year, with gross profit of $4 million and a 53% margin.
Operating loss narrowed to $2.7 million, adjusted EBITDA loss halved to $1.4 million, and net loss improved to $3 million.
Completed divestiture of Netherlands operations for $16.1 million, strengthening the balance sheet and focusing on high-margin, strategic initiatives.
Rebranded as MindWalk Inc., unifying legacy companies and introducing new Nasdaq ticker HYFT, emphasizing a bio-native AI platform model.
Cash balance at quarter-end was $5 million, with an additional $16.1 million from the divestiture.
Financial highlights
Q1 revenue reached $7.6 million, a 45% year-over-year increase, including $3.2 million from continuing and $4.4 million from discontinued operations.
Gross profit rose to $4 million (53% margin), with continued operations at $1.5 million (48% margin) and discontinued at $2.5 million (56% margin).
Operating loss (excluding amortization and non-recurring charges) improved to $2.7 million from $4.2 million.
Adjusted EBITDA loss improved to $1.4 million from $2.8 million year over year.
Net loss improved to $3 million from $4 million last year.
Outlook and guidance
Focused on expanding SaaS, data as a service, and translational programs, including the dengue vaccine initiative.
Anticipates stronger gross margin contributions from BioStrand and continued growth in core AI-driven operations.
Rebranding and platform integration expected to drive new partnerships and scalable growth.
Management expects sustainable growth and long-term value, supported by a stronger capital structure and focus on scalable AI-driven opportunities.
Ongoing transformation into a fully integrated BioIntelligence company, with continued investment in AI and biologics platforms.
What is the growth outlook for continuing operations?
LensAI platform commercialization strategy?
Future investments in AI-driven initiatives?
How will BioStrand's SaaS impact future margins?
Dengue vaccine: funding strategy for Phase I
Balance of internal pipeline vs. partnerships?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next ImmunoPrecise Antibodies earnings date
Q2 20269 Dec, 2025
Next ImmunoPrecise Antibodies earnings date
Q2 20269 Dec, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
ImmunoPrecise Antibodies Ltd. engages in antibody production and related services worldwide. It offers purification and affinity maturation of monoclonal antibodies; design, development, and validation of comprehensive service packages for the discovery of novel antibodies against therapeutic targets; custom peptide synthesis services; recombinant protein expression platforms; custom vaccines and neutralizing antibodies for passive transfer applications; and an in vivo passive transfer model for assessing the efficacy of passive immune treatments targeting infectious diseases.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage